BAY 81-8973, a full-length recombinant factor VIII for the treatment of hemophilia A: product review

Johnny N. Mahlangu, Sanjay P. Ahuja, Jerzy Windyga, Nikki Church, Anita Shah, Lawrence Schwartz
  • Therapeutic Advances in Hematology, June 2018, SAGE Publishing
  • DOI: 10.1177/2040620718777903
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: